Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
June 30, 2026 20.87%
March 31, 2026 20.32%
December 31, 2025 9.00%
September 30, 2025 22.90%
June 30, 2025 21.60%
March 31, 2025 20.44%
December 31, 2024 16.11%
September 30, 2024 23.46%
June 30, 2024 24.61%
March 31, 2024 26.38%
December 31, 2023 28.01%
September 30, 2023 28.15%
June 30, 2023 29.46%
March 31, 2023 31.22%
December 31, 2022 32.31%
September 30, 2022 36.62%
June 30, 2022 35.24%
March 31, 2022 44.54%
December 31, 2021 39.96%
September 30, 2021 50.29%
June 30, 2021 53.26%
March 31, 2021 46.50%
December 31, 2020 50.07%
September 30, 2020 54.42%
June 30, 2020 51.52%
Date Value
March 31, 2020 44.93%
December 31, 2019 32.96%
September 30, 2019 30.82%
June 30, 2019 31.56%
March 31, 2019 45.16%
December 31, 2018 79.15%
September 30, 2018 44.74%
June 30, 2018 59.21%
March 31, 2018 48.46%
December 31, 2017 26.60%
September 30, 2017 52.32%
June 30, 2017 62.61%
March 31, 2017 50.54%
December 31, 2016 58.18%
September 30, 2016 44.01%
June 30, 2016 56.94%
March 31, 2016 42.77%
December 31, 2015 -92.17%
September 30, 2015 33.86%
June 30, 2015 -437.2%
March 31, 2015 -181.1%
December 31, 2014 -305.7%
September 30, 2014 -25.15K%
June 30, 2014 -25.15K%
March 31, 2014 -43.20K%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Omeros Corp. 96.50%
Talphera, Inc. --
Hyperion DeFi, Inc. --
Atea Pharmaceuticals, Inc. --
Cencora, Inc. 3.93%

Gross Profit Margin (Quarterly) Related Metrics